At Air Liquide Healthcare Iberia, we are specialists in the manufacture and comercialization of medical and healthcare gases. We manufacture and supply medical gases; we develop, install, maintain equipment and propose essential solutions for their proper use.
We work with the highest safety standards in all our processes to ensure the proper use and handling of our gases, services and equipment at all times. In addition, we have a large team of experts and professionals who have an in-depth knowledge of our customers' needs.
How will you CONTRIBUTE and GROW?
La mision principal de esta posicion será la de asegurar el desarrollo de la zona y el crecimiento de la cifra de negocio asociada. Asimismo, habrá que liderar la transformación del modelo de negocio de Novalab en su zona asignada, evolucionando de un esquema de suministro de producto hacia un modelo de servicio . Por último, la persona actuará como el puente crítico entre las necesidades asistenciales de los centros hospitalarios y la propuesta de valor estratégica de la compañía.
Las funciones concretas a desempeñar son:
FUNCIONES TECNICAS
FUNCIONES COMERCIALES
#LI-JD1
Are you a MATCH?
Serás la persona para esta posición su cumples lo siguientes requisitos:
La persona podrá ser de cualquier provincia de Castilla y Leon- prioridad Salamanca y/o Valladolid.
At Air Liquide, we are committed to build a diverse and inclusive workplace that embraces the diversity of our employees, our customers, patients, community stakeholders and cultures across the world.
We welcome and consider applications from all qualified applicants, regardless of their background. We strongly believe a diverse organization opens up opportunities for people to express their talent, both individually and collectively and it helps foster our ability to innovate by living our fundamentals, acting for our success and creating an engaging environment in a changing world.

Air Liquide is a world leader in gases, technologies and services for industry and healthcare. Present in 72 countries with 67,800 employees, the Group serves more than 4 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the Group’s activities since its creation in 1902.
Taking action today while preparing the future is at the heart of Air Liquide’s strategy. With ADVANCE, its strategic plan for 2025, Air Liquide is targeting a global performance, combining financial and extra-financial dimensions. Positioned on new markets, the Group benefits from major assets such as its business model combining resilience and strength, its ability to innovate and its technological expertise. The Group develops solutions contributing to climate and the energy transition—particularly with hydrogen—and takes action to progress in areas of healthcare, digital and high technologies.
Air Liquide’s revenue amounted to more than 27.5 billion euros in 2023. Air Liquide is listed on the Euronext Paris stock exchange (compartment A) and belongs to the CAC 40, CAC 40 ESG, EURO STOXX 50, FTSE4Good and DJSI Europe indexes.